The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

被引：0
|
作者：
C. J. Currie
C. D. Poole
E. A. M. Gale
机构：
[1] Cardiff University,School of Medicine
[2] The Pharma Research Centre,Department of Epidemiology
[3] Cardiff MediCentre,Diabetes and Metabolism, School of Medicine
[4] Pharmatelligence,undefined
[5] Bristol University,undefined
来源：
Diabetologia | 2009年 / 52卷
关键词：
Cancer; Insulin; Insulin analogues; Metformin; Sulfonylureas; Survival; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1766 / 1777
页数：11
相关论文
共 50 条
  • [1] The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
    Currie, C. J.
    Poole, C. D.
    Gale, E. A. M.
    DIABETOLOGIA, 2009, 52 (09) : 1766 - 1777
  • [2] Glucose-lowering therapies in type 2 diabetes: Opportunities and challenges for peptides
    Bailey, Clifford J.
    PEPTIDES, 2018, 100 : 9 - 17
  • [3] Glucose-lowering therapies in patients with type 2 diabetes and cardiovascular diseases
    Prattichizzo, Francesco
    La Sala, Lucia
    Ryden, Lars
    Marx, Nikolaus
    Ferrini, Marc
    Valensi, Paul
    Ceriello, Antonio
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (2_SUPPL) : 73 - 80
  • [4] Glucose-lowering therapies and cancer risk: the trials and tribulations of trials and observations
    Johnson, J. A.
    Yasui, Y.
    DIABETOLOGIA, 2010, 53 (09) : 1823 - 1826
  • [5] Glucose-lowering therapies and cancer risk: the trials and tribulations of trials and observations
    J. A. Johnson
    Y. Yasui
    Diabetologia, 2010, 53 : 1823 - 1826
  • [6] Glucose-lowering medicines for type 2 diabetes
    Davoren, Peter
    AUSTRALIAN FAMILY PHYSICIAN, 2015, 44 (05) : 272 - 276
  • [7] Effect of different glucose-lowering therapies on cancer incidence in type 2 diabetes: An observational population-based study
    Vicentini, Massimo
    Ballotari, Paola
    Rossi, Paolo Giorgi
    Venturelli, Francesco
    Sacchettini, Claudio
    Greci, Marina
    Mangone, Lucia
    Pezzarossi, Annamaria
    Manicardi, Valeria
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 143 : 398 - 408
  • [8] Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes
    Kalyani, Rita R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (13) : 1248 - 1260
  • [9] Cardiovascular Effects of Glucose-lowering Therapies for Type 2 Diabetes: New Drugs in Perspective
    Thompson, Peter L.
    Davis, Timothy M. E.
    CLINICAL THERAPEUTICS, 2017, 39 (05) : 1012 - 1025
  • [10] Cardiovascular Disease and Oral Agent Glucose-Lowering Therapies in the Management of Type 2 Diabetes
    Home, Philip
    DIABETES TECHNOLOGY & THERAPEUTICS, 2012, 14 : S33 - S42
12345